This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Qiagen, LLC, a division of Qiagen N.V. The contract provides for the full maintenance renewal of QIACUITY EIGHT, which is described as an AMBIS #2252931 product. The contract has a ceiling value of $19,531.80 and a performance period that runs through February 27, 2026. The award is not associated with a set-aside program. Qiagen is a provider of sample and assay technologies that has supported various federal agencies' biomedical research, public health, and healthcare programs through past prime and subcontract awards, including the supply of DNA/RNA extraction kits, sequencing equipment, and bioinformatics software.
Generated 3/1/25, 10:18 AM